Literature DB >> 3622434

Biological effects of short-term, high-concentration exposure to methyl isocyanate. VI. In vitro and in vivo complement activation studies.

W P Kolb, J R Savary, C M Troup, D E Dodd, J D Tamerius.   

Abstract

The ability of MIC to induce complement activation in vitro and in vivo was investigated. For the in vitro studies, both human and guinea pig serum or EDTA-plasma samples were exposed to 1167 to 1260 ppm MIC vapor for 15 min at room temperature. The human serum samples exposed to MIC showed significant reductions in Factor B, C2, C4, C3, C5, and total hemolytic complement CH50 activity levels. C6 functional activity was unaffected. The C3, C5, and CH50 functional activities in guinea pig serum (the only functional tests conducted on these samples) were more sensitive to MIC-mediated reduction than the corresponding activity reductions observed in the human serum samples. The human and single guinea pig EDTA-plasma samples exposed to MIC vapor showed no evidence of C3 consumption but did show significant reductions in CH50 levels. Thus, MIC vapor was able to activate, and thereby reduce serum complement C3 activity in vitro by a complement-dependent process. However, the data suggest at least one complement component other than C3 was inactivated in EDTA-plasma by a complement-independent mechanism. For the in vivo studies, five pairs of guinea pigs were exposed to 644 to 702 ppm MIC vapor until one of the pair died (11-15 min). MIC exposure was then discontinued, the surviving guinea pig was sacrificed, and EDTA-plasma was obtained from both animals and analyzed for complement consumption.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622434      PMCID: PMC1474634          DOI: 10.1289/ehp.8772189

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  26 in total

Review 1.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.

Authors:  R D Schreiber; M K Pangburn; P H Lesavre; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 3.  Anaphylatoxins: C3a and C5a.

Authors:  T E Hugli; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

4.  Chemotactic factor inactivators of human granulocytes.

Authors:  J P Brozna; R M Senior; D L Kreutzer; P A Ward
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

5.  Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value.

Authors:  D E Hammerschmidt; L J Weaver; L D Hudson; P R Craddock; H S Jacob
Journal:  Lancet       Date:  1980-05-03       Impact factor: 79.321

6.  Immune-complex disease in guinea pig lungs. I. Elicitation by aerosol challenge, suppression with cobra venom factor, and passive transfer with serum.

Authors:  A K Roska; J C Garancis; V L Moore; P Abramoff
Journal:  Clin Immunol Immunopathol       Date:  1977-09

7.  Hypersensitivity pneumonitis in the monkey.

Authors:  G T Hensley; J N Fink; J J Barboriak
Journal:  Arch Pathol       Date:  1974-01

8.  Role of complement activation in a model of adult respiratory distress syndrome.

Authors:  S Hosea; E Brown; C Hammer; M Frank
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

9.  Lung inflammation induced by complement-derived chemotactic fragments in the alveolus.

Authors:  J O Shaw; P M Henson; J Henson; R O Webster
Journal:  Lab Invest       Date:  1980-05       Impact factor: 5.662

10.  A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation.

Authors:  G L Larsen; K McCarthy; R O Webster; J Henson; P M Henson
Journal:  Am J Pathol       Date:  1980-07       Impact factor: 4.307

View more
  7 in total

1.  Methyl isocyanate inhalation induces tissue factor-dependent activation of coagulation in rats.

Authors:  Raymond C Rancourt; Jacqueline S Rioux; Livia A Veress; Rhonda B Garlick; Claire R Croutch; Eric Peters; William Sosna; Carl W White
Journal:  Drug Chem Toxicol       Date:  2018-11-14       Impact factor: 3.356

2.  Effect of methyl isocyanate on rabbit cardiac Na+, K(+)-ATPase.

Authors:  K Jeevaratnam
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

3.  Acute toxicity of methyl isocyanate in mammals. II. Induction of hyperglycemia, lactic acidosis, uraemia, and hypothermia in rats.

Authors:  K Jeevaratnam; R Vijayaraghavan; M P Kaushik; C S Vaidyanathan
Journal:  Arch Environ Contam Toxicol       Date:  1990 May-Jun       Impact factor: 2.804

4.  Acute toxicity of methyl isocyanate in rabbit: in vitro and in vivo effects on rabbit erythrocyte membrane.

Authors:  K Jeevaratnam; C S Vaidyanathan
Journal:  Arch Environ Contam Toxicol       Date:  1992-04       Impact factor: 2.804

5.  Biological effects of short-term, high-concentration exposure to methyl isocyanate. V. Morphologic evaluation of rat and guinea pig lungs.

Authors:  E H Fowler; D E Dodd; C M Troup
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

6.  Biological effects of short-term, high-concentration exposure to methyl isocyanate. II. Blood chemistry and hematologic evaluations.

Authors:  C M Troup; D E Dodd; E H Fowler; F R Frank
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

7.  Biological effects of short-term, high-concentration exposure to methyl isocyanate. I. Study objectives and inhalation exposure design.

Authors:  D E Dodd; F R Frank; E H Fowler; C M Troup; R M Milton
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.